In the present study, we identified a synthetic dsRNA (dsP53-285) exhibited considerable potency to activate wild-type p53 expression by targeting promoter in human bladder cancer T24 and EJ cells. This evidence concerns the gene TP53 and urinary bladder carcinoma.